POP BIO and FunPep Announce Collaboration for Antibody-Inducing Peptide Therapy

EIN Newswire reported that Pop Biotech, a biotechnology company developed by Jonathan Lovell, has developed an antibody-inducing peptide therapy. The article was picked up by the Associated Press.